News

Deal Announcements

BioDirection Raises New Venture Capital Funding

Tuesday, January 6, 2015 5:33:00 AM PDT | VentureDeal
   Oro Valley, Arizona  --  Diagnostics technology company BioDirection has raised $1.6 million in new equity investment, according to an SEC regulatory filing.

BioDirection is developing a low-cost, rapid, point of care screening test for mild traumatic injury or concussion.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

BioDirection previously raised $3.95 million for its Series A financing round in August 2013.

The company has not disclosed its investor base, but said that the proceeds of the Series A round were to be used to complete the miniaturization of its biosensor test platform.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1